Company: RPID
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001380106-25-000200
Chunk: 204

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 204
---
 2025 and December 31, 2024— — Additional paid-in capital553,778 550,157 Accumulated deficit(509,900)(475,274)Accumulated other comprehensive income12 39 Total stockholders’ equity44,332 75,352 Total liabilities and stockholders’ equity$84,407 $98,169 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Table of Contents

RAPID MICRO BIOSYSTEMS, INC.

Condensed consolidated statements of operations

(Unaudited)

(In thousands, except share and per share amounts)

Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Revenue:Product revenue$5,214 $5,255 $14,117 $13,505 Service revenue2,624 2,349 8,188 6,328 Total revenue7,838 7,604 22,305 19,833 Costs and operating expenses:Cost of product revenue5,563 5,314 15,907 15,404 Cost of service revenue1,579 1,668 5,023 5,519 Research and development3,529 3,609 10,383 11,195 Sales and marketing2,895 3,376 8,760 10,284 General and administrative5,644 5,676 17,413 17,121 Total costs and operating expenses19,210 19,643 57,486 59,523 Loss from operations(11,372)(12,039)(35,181)(39,690)Other income (expense):Interest income347 779 1,188 2,617 Interest expense(393)(11)(417)(28)Other expense, net(79)(39)(190)(91)Total other income (expense), net(125)729 581 2,498 Loss before income taxes(11,497)(11,310)(34,600)(37,192)Income tax expense8 13 26 31 Net loss$(11,505)$(11,323)(34,626)(37,223)Net loss per share — basic and diluted$(0.26)$(0.26)$(0.78)$(0.86)Weighted average common shares outstanding — basic and diluted44,956,13143